AAOTI develops wound-care technology for chronic wounds, led by a multi-modality topical wound oxygen therapy. It delivers oxygen directly to the wound site to support healing and is designed to fit into existing clinical care without disrupting practices. The approach stands out through strong clinical validation and endorsements from major medical organizations, such as ADA and IWGDF, and by focusing on easy integration into standard care. Its goal is to improve patient outcomes, reduce amputations, and expand access to high-quality wound care for all patients.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
IPO
Headquarters
Oceanside, CA
Founded
2004
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$25.7M
Above
Industry Average
Funded Over
1 Rounds
AOTI reported strong earnings that lifted its share price, but underlying cash flow metrics suggest caution. For the year to December 2025, the company posted a profit of $2.67 million but burnt through $6.6 million in free cash flow, resulting in an accrual ratio of 0.43. The high accrual ratio indicates the company's profit significantly exceeds its free cash flow, which research suggests may signal weaker future profitability. AOTI generated no free cash flow during the period and also recorded negative cash flow in the previous year. Whilst the company improved from a prior-year loss to profitability, the disconnect between reported earnings and cash generation raises questions about the sustainability of its earnings power.
Helix Exploration has become Montana's first helium producer, with operations scaling up at its Rudyard project as the company enters distributor discussions. Atlantic Lithium has rejected takeover talks, stating the offer undervalued its flagship Ewoyaa Lithium Project in Ghana. The board will focus on its own growth strategy instead. AOTI Inc reported a 14% increase in 2025 annual revenue to over $66 million and is awaiting a potentially transformational US reimbursement decision for its medical technology. Caledonia Mining has appointed Stanbic Bank Zimbabwe and CBZ Bank as lead banks for a new $150 million funding facility. The capital will support development of its Bilboes gold project in Zimbabwe.
AOTI recently raised net proceeds of 13.5 million GBP (17.5 million USD) through an initial public offering ("IPO") on the AIM market on 18 June 2024.
By Ian Walker U.S. medical-technology company AOTI raised 19.5 million pounds ($24.8 million) in its initial public offering and started trading on London's...
AOTI has all of the building blocks in place to secure expanded market access and commercialisation of our TWO2 Therapy and to continue the staged roll-out of the NEXA NPWT System
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
51-200
Company Stage
IPO
Headquarters
Oceanside, CA
Founded
2004
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs